Daehwa Nobre Tablet (Phentermine Hydrochloride)

Adult dose

Adults: Administer 37.5 mg of phentermine hydrochloride orally once daily before breakfast or 1–2 hours after breakfast. Use the minimum effective dose, adjusting it individually to achieve an adequate response. A dose of 18.75 mg once daily may be appropriate for some patients, while in some cases it may be preferable to take 18.75 mg twice daily. Avoid taking this medicine late at night because it may cause insomnia. This medicine should be administered for a short period (within 4 weeks). However, to reduce the risk of inappropriate use and associated risks, treatment with this medicine may be continued if the patient achieves satisfactory weight loss within the first 4 weeks (weight loss of at least 1.8 kg, or weight loss judged satisfactory by both the physician and the patient).

This medication should not be used in conjunction with other appetite suppressants and should only be taken alone for a short period. It is not recommended to take this medication in combination with other drugs for weight loss due to safety concerns. If symptoms such as dyspnea, chest pain, syncope, or leg edema, which are early signs of a serious lung disease called primary pulmonary hypertension, occur during treatment, it is essential to inform a physician immediately. This medication may also be associated with valvular heart diseases, so its long-term high-dose use or concurrent use with other appetite suppressants should be avoided. Individuals with advanced arteriosclerosis, cardiovascular diseases, severe hypertension, pulmonary hypertension, hyperthyroidism, glaucoma, severe anxiety states, or a history of substance abuse should not take this medication. Women who are pregnant or may become pregnant and children under 16 years of age should also avoid using this medication. Diabetic patients and those with mild hypertension should use this medication with caution, and insulin dosage adjustments may be necessary for diabetic patients. During treatment, side effects such as anxiety, dizziness, insomnia, palpitations, and elevated blood pressure may occur, so caution is needed. This medication affects the central nervous system, requiring attention when driving or operating machinery. Alcohol consumption should be avoided as it may lead to dangerous interactions. In cases of overdose, severe toxicity symptoms may develop, and immediate medical attention is required. Store out of reach of children, and use under professional supervision as this medication may be habit-forming.

Primary pulmonary hypertension, regurgitant heart valve disease, palpitations, tachycardia, hypertension, over-stimulation, anxiety, dizziness, insomnia, discomfort, euphoria, tremors, headaches, psychotic seizures, thirst, unpleasant taste, diarrhea, constipation, other gastrointestinal disturbances, urticaria, erectile dysfunction, changes in sexual drive, anxiety, coma, rebound tachycardia, rapid breathing, confusion, hallucinations, aggression, panic state, convulsions in case of fatal overdose, coma, death, severe fatigue after central nervous system excitation, depression, arrhythmia, hypertension, hypotension, circulatory shock, nausea, vomiting, abdominal pain, severe skin disease, irritability, hyperfunction, personality changes, schizophrenia-like mental disorders

This medication should be stored in a tightly closed container to protect it from air or moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature. This helps preserve the effectiveness of the medication and prevents degradation.

Appearance

White round tablets

Package unit

30 tablets/bottle, 300 tablets/bottle